Home>>Annual Meeting


Symposium Organization and Continuing Medical Education (CME)
 
Symposium Organizer and Co-Chair
As an accredited provider of continuing medical education (CME) by the Accreditation Council for Continuing Medical Education (ACCME), a representative of an ACCME-defined ineligible company cannot have an organizational role in a symposium program as Symposium Organizer or Co-Chair. The ACCME defines an ineligible company as one whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
 
Financial Disclosure
ACCME requires ASTMH to document that anyone in a position to control the content of an educational activity has disclosed all financial relationships with an ACCME-defined ineligible company.  ASTMH must then mitigate relevant financial relationships so as not affect the content of the presentation.
 
If your symposium proposal is accepted for presentation, Symposium Organizers are required to collect a financial disclosure form for each proposed speaker. Financial disclosure information provided by speakers in CME-accredited sessions will be published and distributed to Annual Meeting attendees.
 
Symposium Content
ASTMH maintains responsibility for and controls all symposium content. Symposia must promote improvements or quality in healthcare and science and not a specific proprietary interest of an ACCME-defined ineligible company. Presentations must give a balanced view of therapeutic options and reference the best available evidence. Use of generic names will contribute to this impartiality.
 
Content Validation
All Symposium Organizers, Co-Chairs and speakers must attest that all the recommendations for patient care in a symposium are based on current science, evidence and clinical reasoning, while giving a fair and balanced view of diagnostic and therapeutic options. All scientific research referred to, reported or used in this symposium in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, analysis and interpretation.
 
Symposium Organizers, Co-Chairs and speakers must acknowlege that when discussing unlabeled or investigational uses of a commercial product, these uses must be identified as unlabeled; that the use of generic names of products contributes to impartiality; and that if trade names are used, those of several companies should be used.
 
GoTropMed